Front page

Private equity investors should brace for more uncertainty around inflation and asset valuations in the months ahead after deal volumes slowed in the first six months of the year.

North American GPs accounted for 89% of Petershill Partners' invested capital as of end-December, with the remainder in Europe, according to its maiden full-year earnings.

A host of private markets participants have flocked to Asia-Pacific in recent years as the size and depth of its private wealth community soars.

A host of potential entrants to the double-digit fund club, a raft of fund closes below target and an influx of Indian investment are on the cards in the year ahead.

GP-led secondaries, especially single-asset deals such as this one involving a global glass repair operator, have driven the market to expected record volume levels this year.

Ascentium founder and former Credit Suisse boss James Lee will become head of Blue Owl’s institutional sales team in Asia, per a statement seen exclusively by PEI.

At PEI's recent Operating Partners Forum, executives from firms including Permira and Antin Infrastructure said sellers are primarily driven by the ability of the buyer to execute on a difficult transaction.

The European giant will not rule out a dedicated life sciences growth fund in the medium term, co-head of global healthcare Michael Bauer told PEI.

The GP stakes firm plans to deploy as much as $300m each year using the company’s own money, leverage and proceeds from the planned $5bn listing.

The buyer would join Singapore's GIC and the Kuwait Investment Authority which acquired part of a 10% stake in the buyout stalwart in 2012.